1,0
22 déc. 2016
Employé (anonyme)
Employé (ancien)
Recommande
Approbation du PDG
Perspective commerciale
Avantages
BioTime successfully transitioned from blood products to stem cell focus at an excellent time, and attracted some strong backers with excellent resources and know-how.
Inconvénients
Internal management is scattered and unfocused. CEO Mike West consistently opts for expenditures based on personal whims and self-glorification rather than overall company well-being. Rewards are rarely based on merit.